Terms: = Head and neck cancer AND FGFR2, BFR-1, 2263, ENSG00000066468, TK14, BEK, CD332, JWS, TK25, ECT1, CEK3, K-SAM, CFD1, KGFR AND Diagnosis
11 results:
1. FGFR1/2/3-rearranged carcinoma of the head and neck: expanded histological spectrum crossing path with high-risk HPV in the sinonasal tract.
Chu YH; Mullaney K; DiNapoli SE; Cohen MA; Xu B; Ghossein R; Katabi N; Dogan S
Histopathology; 2024 Mar; 84(4):589-600. PubMed ID: 38010295
[TBL] [Abstract] [Full Text] [Related]
2. Detecting undetectable - epidemiology, etiology, and diagnosis of carcinoma of unknown primary - systematic review.
Ostojewska J; Wieczorek I; Pachciński O; Zdziennicki W; Burdan F
Folia Med Cracov; 2023 Apr; 63(1):19-37. PubMed ID: 37406274
[TBL] [Abstract] [Full Text] [Related]
3. Ameloblastoma with adenoid features: Case report with cyto-histopathologic correlation and molecular findings.
Jofre SA; Roth M; Lahouti AH; Gersten A; Azad AK; Kelsch RD; Asiry S; Goldstein Y; Naeem R; Rao R
Diagn Cytopathol; 2022 Jun; 50(6):E140-E145. PubMed ID: 35077030
[TBL] [Abstract] [Full Text] [Related]
4. The Integrated Analyses of Driver Genes Identify Key Biomarkers in Thyroid cancer.
Xu Q; Song A; Xie Q
Technol Cancer Res Treat; 2020; 19():1533033820940440. PubMed ID: 32812852
[TBL] [Abstract] [Full Text] [Related]
5. Tendencies of fgfr2 rs2981582 polymorphism in patients with oral cancer.
Liutkevicius V; Tamauskaite T; Vilkeviciute A; Liutkeviciene R; Smalinskaite R; Giedraitiene A; Smalinskiene A; Uloza V
Stomatologija; 2020; 22(1):3-8. PubMed ID: 32706340
[TBL] [Abstract] [Full Text] [Related]
6. MicroRNA-1266 suppresses papillary thyroid carcinoma cell metastasis and growth via targeting fgfr2.
Fu YT; Zheng HB; Zhang DQ; Zhou L; Sun H
Eur Rev Med Pharmacol Sci; 2018 Jun; 22(11):3430-3438. PubMed ID: 29917195
[TBL] [Abstract] [Full Text] [Related]
7. An integrated method for the identification of novel genes related to oral cancer.
Chen L; Yang J; Xing Z; Yuan F; Shu Y; Zhang Y; Kong X; Huang T; Li H; Cai YD
PLoS One; 2017; 12(4):e0175185. PubMed ID: 28384236
[TBL] [Abstract] [Full Text] [Related]
8. Fibroblast growth factor receptor-2 expression in thyroid tumor progression: potential diagnostic application.
Redler A; Di Rocco G; Giannotti D; Frezzotti F; Bernieri MG; Ceccarelli S; D'Amici S; Vescarelli E; Mitterhofer AP; Angeloni A; Marchese C
PLoS One; 2013; 8(8):e72224. PubMed ID: 23977259
[TBL] [Abstract] [Full Text] [Related]
9. Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis.
Dulak AM; Schumacher SE; van Lieshout J; Imamura Y; Fox C; Shim B; Ramos AH; Saksena G; Baca SC; Baselga J; Tabernero J; Barretina J; Enzinger PC; Corso G; Roviello F; Lin L; Bandla S; Luketich JD; Pennathur A; Meyerson M; Ogino S; Shivdasani RA; Beer DG; Godfrey TE; Beroukhim R; Bass AJ
Cancer Res; 2012 Sep; 72(17):4383-93. PubMed ID: 22751462
[TBL] [Abstract] [Full Text] [Related]
10. Keratinocyte growth factor colocalized with perlecan at the site of capsular invasion and vascular involvement in salivary pleomorphic adenomas.
Maruyama S; Cheng J; Yamazaki M; Liu A; Saku T
J Oral Pathol Med; 2009 Apr; 38(4):377-85. PubMed ID: 19228276
[TBL] [Abstract] [Full Text] [Related]
11. Immunohistological analysis of thymoma by molecules differentially expressed in the thymic cortex and medulla, and its application in the differential diagnosis of thymoma from esophageal and lung cancer.
Shiraishi J; Utsuyama M; Akashi T; Nemoto T; Ohashi K; Akamatsu H; Sunamori M; Kitagawa M; Hirokawa K
Pathol Res Pract; 2001; 197(9):611-9. PubMed ID: 11569925
[TBL] [Abstract] [Full Text] [Related]
